Results
210
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
210 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$45.84 | 15.3% | 143.3% | US$7.7b | US$37.58 | PS35x | E95.0% | n/a | Semiconductors | ||
ONON | US$58.13 | 12.0% | 104.1% | US$18.0b | US$58.64 | PE132.1x | E29.6% | n/a | Consumer Durables | ||
ALKT | US$40.69 | 13.2% | 78.6% | US$3.9b | US$44.30 | PS13x | E98.6% | n/a | Software | ||
EH | US$14.06 | -15.0% | -20.0% | US$841.1m | US$24.32 | PS18.5x | E81.0% | n/a | Capital Goods | ||
ATAT | US$25.27 | -2.8% | 33.3% | US$3.5b | US$31.17 | PE21.6x | E24.1% | 1.7% | Consumer Services | ||
TBBB | US$34.07 | 5.9% | n/a | US$3.7b | US$31.81 | PS1.6x | E50.7% | n/a | Consumer Retailing | ||
VCTR | US$68.36 | 8.2% | 112.0% | US$4.5b | US$67.11 | PE16.6x | E31.5% | 2.6% | Diversified Financials | ||
SMCI | US$33.15 | 78.4% | 16.0% | US$17.4b | US$40.32 | PE16.1x | E24.3% | n/a | Tech | ||
CCB | US$76.69 | 4.6% | 91.8% | US$1.0b | US$76.25 | PB3.1x | E46.1% | n/a | Banks | ||
CLNN | US$4.17 | -7.9% | -54.7% | US$32.0m | US$45.17 | PS79x | E60.2% | n/a | Pharmaceuticals & Biotech | ||
CACC | US$473.10 | 6.2% | 8.7% | US$5.6b | US$426.50 | PE30.2x | E50.0% | n/a | Diversified Financials | ||
DUOL | US$351.97 | 14.5% | 58.9% | US$15.0b | US$327.23 | PE178.4x | E41.6% | n/a | Consumer Services | ||
ULBI | US$7.63 | 3.7% | 1.3% | US$121.7m | US$14.00 | PE14.1x | E43.8% | n/a | Capital Goods | ||
RH | US$368.01 | 16.6% | 36.9% | US$6.4b | US$330.96 | PE197x | E52.9% | n/a | Retail | ||
CBNK | US$28.56 | 2.5% | 39.6% | US$468.1m | US$30.25 | PB1.7x | E29.9% | 1.4% | Banks | ||
HSAI | US$4.74 | 16.2% | -52.4% | US$587.7m | US$6.88 | PS2.4x | E71.8% | n/a | Automobiles | ||
SMWB | US$12.57 | 9.2% | 139.9% | US$1.0b | US$14.43 | PS4.3x | E126.3% | n/a | Software | ||
RYAN | US$73.53 | 3.7% | 59.8% | US$18.8b | US$73.48 | PE90.5x | E44.5% | 0.6% | Insurance | ||
SPRY | US$14.00 | -0.07% | 194.1% | US$1.3b | US$26.50 | PS529.8x | E69.8% | n/a | Pharmaceuticals & Biotech | ||
LOOP | US$1.41 | 12.8% | -60.6% | US$62.9m | US$4.50 | PS664.8x | E63.5% | n/a | Materials | ||
WULF | US$7.45 | 3.8% | 491.3% | US$2.7b | US$9.69 | PS22.4x | E113.5% | n/a | Software | ||
CORT | US$57.54 | 11.0% | 127.2% | US$5.9b | US$74.90 | PE42.9x | E41.0% | n/a | Pharmaceuticals & Biotech | ||
DUOT New | US$4.58 | 21.8% | 48.2% | US$39.3m | US$8.00 | PS5x | E89.6% | n/a | Software | ||
MYO | US$5.09 | 9.2% | 58.1% | US$145.2m | US$7.33 | PS6.1x | E71.6% | n/a | Healthcare |